drugset / Trial / NCT01332214
To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses
RandomizedParallel-groupSingle-blindBasic science
Summary
This is a randomised, single-blind, placebo-controlled Phase I study to investigate the safety, tolerability and pharmacokinetics after administration of single doses of AZD2820 to healthy male subjects.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD2820 | Unknown | — | Subcutaneous |
Indications
No indication recorded.